RREVU — RRE Ventures Acquisition Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2123969 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 456,407 | — | 491,418 |
| Feb 2026 | — | — | — | — | 311,274 | — | 312,402 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-60,011
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.68B | $36.44 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $647.19M | $10.16 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $484.03M | $10.31 | — |
| BCSS | Bain Capital GSS Investment Corp. | $483.54M | $10.31 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $472.77M | $10.30 | — |
Recent Insider Activity
No insider activity indexed for this ticker.